Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control
S Stock, AK Klüver, L Fertig… - … Journal of Cancer, 2023 - Wiley Online Library
The clinical application of chimeric antigen receptor (CAR) T‐cell therapy has rapidly
changed the treatment options for terminally ill patients with defined blood‐borne cancer …
changed the treatment options for terminally ill patients with defined blood‐borne cancer …
Next-generation approaches to immuno-oncology in GI cancers
JR Hecht, J Mitchell, MP Morelli… - American Society of …, 2023 - ascopubs.org
Immunotherapy has only had a modest impact on the treatment of advanced GI
malignancies. Microsatellite-stable colorectal cancer and pancreatic adenocarcinoma, the …
malignancies. Microsatellite-stable colorectal cancer and pancreatic adenocarcinoma, the …
[HTML][HTML] BASECAMP-1: Trial of Novel CAR T-Cell Agent Seeks Patients Eligible for Treatment
K Doherty - cgtlive.com
BASECAMP-1: Trial of Novel CAR T-Cell Agent Seeks Patients Eligible for Treatment HomeNews
Media All VideosClinical Trials in ProgressImmunoLogicNews Network PartnersCME/CEConferencesSponsoredSubscribe …
Media All VideosClinical Trials in ProgressImmunoLogicNews Network PartnersCME/CEConferencesSponsoredSubscribe …
[HTML][HTML] Harnessing a Unique Approach With A2B530 to Bring CAR T Treatment to Solid Tumors
K Doherty - cgtlive.com
The BASECAMP-1 clinical trial (NCT04981119) is now underway, initiated by investigators
with an aim to identify patients with advanced solid tumors who would qualify for another …
with an aim to identify patients with advanced solid tumors who would qualify for another …